Zofenopril Plus Hydrochlorothiazide and Irbesartan Plus Hydrochlorothiazide in Previously Treated and Uncontrolled Diabetic and Non-diabetic Essential Hypertensive Patients
Main Authors: | Agabiti-Rosei, Enrico, Manolis, Athanasios, Zava, Dario, Omboni, Stefano |
---|---|
Format: | Online |
Language: | English |
Published: |
Springer Healthcare
2014
|
Online Access: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3930838/ |
Similar Items
-
Blood Pressure Response to Zofenopril or Irbesartan Each Combined with Hydrochlorothiazide in High-Risk Hypertensives Uncontrolled by Monotherapy: A Randomized, Double-Blind, Controlled, Parallel Group, Noninferiority Trial
by: Malacco, Ettore, et al.
Published: (2015) -
Fixed combination of zofenopril plus hydrochlorothiazide in the management of hypertension: a review of available data
by: Borghi, Claudio, et al.
Published: (2006) -
СHOICE OF ZOFENOPRIL AND HYDROCHLOROTHIAZIDE COMBINATION IN THE TREATMENT OF ARTERIAL HYPERTENSION
by: N. A. Dzhaiani
Published: (2011-01-01) -
Introducing candesartan 32 mg plus hydrochlorothiazide 25 mg in previously untreated patients with severe essential hypertension
by: Baumgart, Peter, et al.
Published: (2011) -
A validated stability indicating HPTLC method for simultaneous estimation of irbesartan and hydrochlorothiazide
by: Khodke, Amol S, et al.
Published: (2010)